NTT Com Launches Enterprise Cloud WebRTC Platform Globally
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), announced today the global launch of its Enterprise Cloud WebRTC Platform (ECL WebRTC), a service enabling the same-day deployment of online real-time communication functions such as voice & video communications and data transmission capabilities on smartphones, tablets and web applications.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170912005815/en/
Figure (Graphic: Business Wire)
The ECL WebRTC platform offers the following benefits:
- Software Development Kits (SDKs), offering video, voice and data transmission capabilities; the service will deliver four kinds of SDKs compatible with web browsers, iOS, Android or IoT.
- By equipping applications and websites with ECL WebRTC, customers can quickly deploy real-time communication functions such as multi-person video & voice conferencing, as well as data transmission.
- NTT Com supplies and operates all server infrastructure required for WebRTC; customers can focus on their own service development and delivery.
- The service will be made available to enterprises via a subscription plan providing full technical support and a Service Level Agreement offering 99.99% availability; start-up enterprises and developers can sign up online for free-of-charge plans offering limited capacity usage (please see the Appendix for more information).
ECL WebRTC is an NTT Com service that operates servers required for the use of Web Real-Time Communication (WebRTC) capabilities, the standardized technology to realize real-time communication, and that provides software development kit (SDK). WebRTC is a technology that allows web browsers and iOS, Android or IoT devices to send and receive real-time media, demand for which has been driven by the increase in remote working, teleconferencing and distance learning, as well as the growth of online call centers and online translation. In 2013 NTT Com launched SkyWay, Japan’s first WebRTC platform, now used by approximately 5,000 developers, 8,000 applications and 300,000 users. To meet the evolving needs of the marketplace, NTT Com has now launched ECL WebRTC, a fully-fledged commercial service based on the technologies used in SkyWay.
Enterprise Cloud WebRTC Platform Official Site
NTT Communications to Release Trial of SkyWay WebRTC Platform with
TURN Feature (press release on January 27, 2015):
NTT Communications Offers World’s 1st Speech-Recognition API for
Multiple Browsers at No Charge (press release on July 28, 2015):
About NTT Communications Corporation
NTT Communications provides consultancy, architecture, security and
cloud services to optimize the information and communications technology
(ICT) environments of enterprises. These offerings are backed by the
company’s worldwide infrastructure, including the leading global tier-1
IP network, the Arcstar Universal One™ VPN network reaching 196
countries/regions, and 140 secure data centers worldwide. NTT
Communications’ solutions leverage the global resources of NTT Group
companies including Dimension Data, NTT DOCOMO and NTT DATA.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com | LinkedIn@NTT Com
Functions of ECL WebRTC (SDK/Server API)
Server API: Signaling, STUN, TURN, SFU (optional services)
Signaling: exchanges information including IP address and port numbers required for connection between devices.
STUN: obtains global IP address and port numbers of the device.
TURN: enables the use of WebRTC in network environments where P2P communication cannot be used, such as enterprise networks, via data relaying.
SFU: A type of media server that distributes data received from one device to other devices and enables communication between a greater number of people. SFU reduces encoding load on the device and bandwidth, as well as the quantity of sent data when communication is with more than three people.
IoT SDK β version: SDK for developing Linux/Raspberry Pi applications.
|Fee-Liable Plans||Free of Charge Plans|
|Price||Basic||2.480JPY per min, with an upper limit of 100,000 JPY per month*||-|
Free of charge for up to one million events, 100,000 JPY thereafter
|TURN/SFU||40 JPY/GB per one In/Out||-|
|Limit of use||Number of times of Signaling||-||Up to 500,000 times per month|
|Amount of TURN||-||500GB per month|
|Amount of SFU||-||500GB per month|
|Support||Ticket support and developers’ community||Developers’ community only|
* The basic fee will be charged for each tenant. Customers can make more than one API key for WebRTC in each tenant.
Mr. Yasumasa Morita / Mr. Masayuki Hayashi / Ms. Yuko Tomita, +81 3 6733 9521
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference19.4.2018 15:45 | Pressemelding
Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced that Rodolphe Hajj, Ph.D., the Company’s Chief Pharmacology Officer, will present at the 8th Annual Global Orphan Drug Conference. The presentation will take place as follows: Date & Time: Wednesday April 25th at 4:40 pm EST Title: “Next generation drug repurposing using network pharmacology to develop new therapeutic entities for rare diseases” Venue: Gaylord National Harbor Hotel, Oxon Hill, MD, U.S. Pharnext’s team will also attend the 2018 American Academy of Neurology Annual Meeting as a first-time exhibitor (booth 908). The meeting will take place on April 21-27, 2018 in Los Angeles, CA, U.S. If you are interested in meeting the Pharnext management team during these events, please send an email to firstname.lastname@example.org. About Pharnext Pharne
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices19.4.2018 15:01 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419005949/en/ Masimo Radical-7® with SpHb® and RD rainbow SET™ Sensor (Photo: Business Wire) In the study, Prof. Baricchi and colleagues in the Transfusion Medicine Unit, AUSL-IRCCS of Reggio Emilia and at the Department of Medicine and Surgery at the University of Parma, Italy, sought to evaluate the appropriateness of post-operative RBC transfusion over a three-year period (2013-2015), before and after implementation of a patient blood managem
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform19.4.2018 14:06 | Pressemelding
Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. The CRO today announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities. Synteract’s leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract’s longstanding, specialized expertise in these complex areas of clinical research. Synteract CEO Steve Powell says, “By aligning operational excel
Nel ASA: Receives Additional Purchase Order from Nikola19.4.2018 14:00 | Pressemelding
Nel ASA (Nel, OSE: NEL) has received a USD 5.5 million purchase order from Nikola Motor Company (Nikola), as part of the previously announced hydrogen stations. “We are very proud to announce that we have received an additional order from Nikola related to the electrolyzer and fueling solution for their prototype trucks. The order marks a strengthening of our partnership and is a recognition of the level of competence our team and hydrogen solutions can offer. We look forward to supplying the demo stations, which will lay the groundwork for the world’s largest, most efficient network of low-cost hydrogen production and fueling sites,” says Jon André Løkke, Chief Executive Officer of Nel. On November 15, 2017, Nikola and Nel announced the exclusive partnership and a purchase order for two so-called demo hydrogen refueling stations for Nikola's fleet of prototype hydrogen trucks. The partnership aims at developing low-cost, renewable hydrogen production and fueling sites for the potentia
Voith and Franka Emika Form a Strategic Partnership19.4.2018 13:39 | Pressemelding
The technology company Voith and the Munich-based robotics company Franka Emika have entered into a strategic partnership. Part of the strategic partnership is the establishment of a new joint venture called Voith Robotics – A Voith and Franka Emika Company. The company, with headquarters in Munich, is to become a global system supplier for robot-assisted automation in the digital age. Voith Robotics will offer self-teaching lightweight robots made by Franka Emika, along with software solutions, apps, services and process consulting, to customers in various industries and markets throughout the world. As part of the strategic partnership Voith will also have a direct stake in Franka Emika, thus emphasizing the long-term and strategic commitment by the two companies to cooperation. Martin Scherrer, formerly a member of the Board of Management of Voith Paper, will be the new chief executive officer of Voith Robotics, which is to be managed by Voith. The still very young market for collab